302 related articles for article (PubMed ID: 23071338)
1. Inhibition of oncogenic Wnt signaling through direct targeting of β-catenin.
Grossmann TN; Yeh JT; Bowman BR; Chu Q; Moellering RE; Verdine GL
Proc Natl Acad Sci U S A; 2012 Oct; 109(44):17942-7. PubMed ID: 23071338
[TBL] [Abstract][Full Text] [Related]
2. Positive feedback regulation between phospholipase D and Wnt signaling promotes Wnt-driven anchorage-independent growth of colorectal cancer cells.
Kang DW; Min do S
PLoS One; 2010 Aug; 5(8):e12109. PubMed ID: 20711340
[TBL] [Abstract][Full Text] [Related]
3. A re-evaluation of the "oncogenic" nature of Wnt/beta-catenin signaling in melanoma and other cancers.
Lucero OM; Dawson DW; Moon RT; Chien AJ
Curr Oncol Rep; 2010 Sep; 12(5):314-8. PubMed ID: 20603725
[TBL] [Abstract][Full Text] [Related]
4. MSX2 is an oncogenic downstream target of activated WNT signaling in ovarian endometrioid adenocarcinoma.
Zhai Y; Iura A; Yeasmin S; Wiese AB; Wu R; Feng Y; Fearon ER; Cho KR
Oncogene; 2011 Oct; 30(40):4152-62. PubMed ID: 21499300
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional Regulation of Wnt/β-Catenin Pathway in Colorectal Cancer.
Bian J; Dannappel M; Wan C; Firestein R
Cells; 2020 Sep; 9(9):. PubMed ID: 32961708
[TBL] [Abstract][Full Text] [Related]
6. The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway.
Chen HJ; Hsu LS; Shia YT; Lin MW; Lin CM
Biochem Pharmacol; 2012 Nov; 84(9):1143-53. PubMed ID: 22935447
[TBL] [Abstract][Full Text] [Related]
7. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.
Kang DW; Lee SH; Yoon JW; Park WS; Choi KY; Min do S
Cancer Res; 2010 May; 70(10):4233-42. PubMed ID: 20442281
[TBL] [Abstract][Full Text] [Related]
8. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
9. Activation of Wnt signaling pathway by human papillomavirus E6 and E7 oncogenes in HPV16-positive oropharyngeal squamous carcinoma cells.
Rampias T; Boutati E; Pectasides E; Sasaki C; Kountourakis P; Weinberger P; Psyrri A
Mol Cancer Res; 2010 Mar; 8(3):433-43. PubMed ID: 20215420
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Wnt signaling by the nuclear pore complex.
Shitashige M; Satow R; Honda K; Ono M; Hirohashi S; Yamada T
Gastroenterology; 2008 Jun; 134(7):1961-71, 1971.e1-4. PubMed ID: 18439914
[TBL] [Abstract][Full Text] [Related]
11. Direct targeting of β-catenin: Inhibition of protein-protein interactions for the inactivation of Wnt signaling.
Hahne G; Grossmann TN
Bioorg Med Chem; 2013 Jul; 21(14):4020-6. PubMed ID: 23566764
[TBL] [Abstract][Full Text] [Related]
12. VBP1 modulates Wnt/β-catenin signaling by mediating the stability of the transcription factors TCF/LEFs.
Zhang H; Rong X; Wang C; Liu Y; Lu L; Li Y; Zhao C; Zhou J
J Biol Chem; 2020 Dec; 295(49):16826-16839. PubMed ID: 32989053
[TBL] [Abstract][Full Text] [Related]
13. Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know?
Mulholland DJ; Dedhar S; Coetzee GA; Nelson CC
Endocr Rev; 2005 Dec; 26(7):898-915. PubMed ID: 16126938
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of PDE5 by sulindac sulfide selectively induces apoptosis and attenuates oncogenic Wnt/β-catenin-mediated transcription in human breast tumor cells.
Tinsley HN; Gary BD; Keeton AB; Lu W; Li Y; Piazza GA
Cancer Prev Res (Phila); 2011 Aug; 4(8):1275-84. PubMed ID: 21505183
[TBL] [Abstract][Full Text] [Related]
15. Parafibromin/Hyrax activates Wnt/Wg target gene transcription by direct association with beta-catenin/Armadillo.
Mosimann C; Hausmann G; Basler K
Cell; 2006 Apr; 125(2):327-41. PubMed ID: 16630820
[TBL] [Abstract][Full Text] [Related]
16. Direct Targeting of β-Catenin by a Small Molecule Stimulates Proteasomal Degradation and Suppresses Oncogenic Wnt/β-Catenin Signaling.
Hwang SY; Deng X; Byun S; Lee C; Lee SJ; Suh H; Zhang J; Kang Q; Zhang T; Westover KD; Mandinova A; Lee SW
Cell Rep; 2016 Jun; 16(1):28-36. PubMed ID: 27320923
[TBL] [Abstract][Full Text] [Related]
17. A Wnt-ow of opportunity: targeting the Wnt/beta-catenin pathway in breast cancer.
Prosperi JR; Goss KH
Curr Drug Targets; 2010 Sep; 11(9):1074-88. PubMed ID: 20545611
[TBL] [Abstract][Full Text] [Related]
18. Distinctive microRNA signature associated of neoplasms with the Wnt/β-catenin signaling pathway.
Sun X; He Y; Huang C; Ma TT; Li J
Cell Signal; 2013 Dec; 25(12):2805-11. PubMed ID: 24041653
[TBL] [Abstract][Full Text] [Related]
19. Bortezomib induces osteoblast differentiation via Wnt-independent activation of beta-catenin/TCF signaling.
Qiang YW; Hu B; Chen Y; Zhong Y; Shi B; Barlogie B; Shaughnessy JD
Blood; 2009 Apr; 113(18):4319-30. PubMed ID: 19196662
[TBL] [Abstract][Full Text] [Related]
20. Targeting the Wnt/β-catenin signaling pathway in human cancers.
Yao H; Ashihara E; Maekawa T
Expert Opin Ther Targets; 2011 Jul; 15(7):873-87. PubMed ID: 21486121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]